Brief: Trinity Biotech Announces The $30 Million Sale Of Its Life Sciences Supply Business To Biosynth
20/04/2023 13:39
April 20 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES THE $30 MILLION SALE OF ITS LIFE
SCIENCES SUPPLY BUSINESS TO BIOSYNTH
* TRINITY BIOTECH ANNOUNCES THE $30 MILLION SALE OF ITS LIFE
SCIENCES SUPPLY BUSINESS TO BIOSYNTH
* TRINITY BIOTECH PLC - TRANSACTION IS EXPECTED TO
SIGNIFICANTLY
REDUCE COMPANY'S NET DEBT BY APPROXIMATELY 40%
Source text for Eikon: ID:nGNX6Q39Zh
Further company coverage: TRIB.O
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM